THREE ARCH PARTNERS IV LP → ACELRX PHARMACEUTICALS INC TLPH

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 21/100

Passive Schedule 13G filer baseline
Elevated short days-to-cover (6.3 DTC)
Short interest building (+47.7% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 6.25

1,065,727 shares short · +47.7% vs prior

Other 13D/G Filings on ACELRX PHARMACEUTICALS INC

Filed	Form	Filer	Stake	Shares
2025-04-03	SCHEDULE	Nantahala Capital Management, LLC	11.70%	1,992,519	view →
2025-04-02	SCHEDULE	Nantahala Capital Management, LLC	11.70%	1,992,519	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →